$CCRD
CoreCard Corp

2021 Q2 Form 10-Q Financial Statement

#000143774921018617 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $13.36M $8.053M
YoY Change 65.84% 7.2%
Cost Of Revenue $5.558M $3.694M
YoY Change 50.46% 27.42%
Gross Profit $7.797M $4.359M
YoY Change 78.87% -5.51%
Gross Profit Margin 58.38% 54.13%
Selling, General & Admin $1.287M $735.0K
YoY Change 75.1% -36.14%
% of Gross Profit 16.51% 16.86%
Research & Development $2.652M $921.0K
YoY Change 187.95% 6.97%
% of Gross Profit 34.01% 21.13%
Depreciation & Amortization $914.0K $390.0K
YoY Change 134.36% 56.0%
% of Gross Profit 11.72% 8.95%
Operating Expenses $3.939M $1.656M
YoY Change 137.86% -17.69%
Operating Profit $3.858M $2.703M
YoY Change 42.73% 3.92%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $81.00K $117.0K
YoY Change -30.77% -19.86%
Pretax Income $3.805M $2.725M
YoY Change 39.63% -0.04%
Income Tax $1.000M $525.0K
% Of Pretax Income 26.28% 19.27%
Net Earnings $2.805M $2.200M
YoY Change 27.5% 4.36%
Net Earnings / Revenue 21.0% 27.32%
Basic Earnings Per Share $0.32 $0.25
Diluted Earnings Per Share $0.32 $0.24
COMMON SHARES
Basic Shares Outstanding 8.798M 8.925M
Diluted Shares Outstanding 8.829M 9.019M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.21M $32.32M
YoY Change -18.9% 45.32%
Cash & Equivalents $26.21M $32.32M
Short-Term Investments
Other Short-Term Assets $1.377M $1.058M
YoY Change 30.15% 53.33%
Inventory
Prepaid Expenses
Receivables $7.048M $8.136M
Other Receivables $220.0K $1.060M
Total Short-Term Assets $34.86M $42.57M
YoY Change -18.13% 57.36%
LONG-TERM ASSETS
Property, Plant & Equipment $7.790M $4.253M
YoY Change 83.16% 63.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.654M $2.160M
YoY Change 22.87% -36.66%
Other Assets $4.304M $3.497M
YoY Change 23.08% 120.63%
Total Long-Term Assets $17.76M $11.45M
YoY Change 55.14% 29.25%
TOTAL ASSETS
Total Short-Term Assets $34.86M $42.57M
Total Long-Term Assets $17.76M $11.45M
Total Assets $52.62M $54.02M
YoY Change -2.6% 50.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.266M $431.0K
YoY Change 193.74% -0.69%
Accrued Expenses $354.0K $238.0K
YoY Change 48.74% 126.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.416M $10.81M
YoY Change -22.16% 115.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.775M $2.320M
YoY Change 19.61% 236.23%
Total Long-Term Liabilities $3.593M $2.596M
YoY Change 38.41% 278.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.416M $10.81M
Total Long-Term Liabilities $3.593M $2.596M
Total Liabilities $12.01M $13.41M
YoY Change -10.43% 134.9%
SHAREHOLDERS EQUITY
Retained Earnings $33.85M $25.09M
YoY Change 34.91% 66.66%
Common Stock $16.29M $15.66M
YoY Change 3.99% 2.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $9.399M
YoY Change
Treasury Stock Shares $258.7K
Shareholders Equity $40.61M $40.61M
YoY Change
Total Liabilities & Shareholders Equity $52.62M $54.02M
YoY Change -2.6% 50.43%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $2.805M $2.200M
YoY Change 27.5% 4.36%
Depreciation, Depletion And Amortization $914.0K $390.0K
YoY Change 134.36% 56.0%
Cash From Operating Activities $2.731M $4.020M
YoY Change -32.06% 79.46%
INVESTING ACTIVITIES
Capital Expenditures -$1.516M $2.230M
YoY Change -167.98% 58.16%
Acquisitions
YoY Change
Other Investing Activities -$963.0K $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.479M -$2.230M
YoY Change 11.17% -7.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.047M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 2.731M 4.020M
Cash From Investing Activities -2.479M -2.230M
Cash From Financing Activities -5.047M 0.000
Net Change In Cash -4.795M 1.790M
YoY Change -367.88% -1152.94%
FREE CASH FLOW
Cash From Operating Activities $2.731M $4.020M
Capital Expenditures -$1.516M $2.230M
Free Cash Flow $4.247M $1.790M
YoY Change 137.26% 115.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000320340
dei Entity Registrant Name
EntityRegistrantName
INTELLIGENT SYSTEMS CORP
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8742599
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9001311
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8929368
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8742599
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8885797
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
258712
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
43571
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26210000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37956000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7048000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3270000 USD
CY2021Q2 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
220000 USD
CY2020Q4 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
0 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1377000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1263000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
34855000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
42489000 USD
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
2654000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
1921000 USD
CY2021Q2 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
3012000 USD
CY2020Q4 ins Notes And Interest Receivable Noncurrent
NotesAndInterestReceivableNoncurrent
2681000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7790000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6914000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4304000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3020000 USD
CY2021Q2 us-gaap Assets
Assets
52615000 USD
CY2020Q4 us-gaap Assets
Assets
57025000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1266000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
714000 USD
CY2021Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1040000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1322000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2368000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1901000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
354000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
321000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
606000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
954000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2782000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4850000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8416000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10062000 USD
CY2021Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
88000 USD
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
818000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
818000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2687000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1994000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3593000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2812000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
90000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
89000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16197000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15836000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
9399000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1639000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-132000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-140000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33850000 USD
ins Noncash Interest Income
NoncashInterestIncome
55000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4190000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
30005000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40606000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44151000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52615000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57025000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13355000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8053000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22267000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15946000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
5558000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
3694000 USD
us-gaap Cost Of Revenue
CostOfRevenue
9986000 USD
us-gaap Cost Of Revenue
CostOfRevenue
7201000 USD
CY2021Q2 us-gaap Marketing Expense
MarketingExpense
46000 USD
CY2020Q2 us-gaap Marketing Expense
MarketingExpense
31000 USD
us-gaap Marketing Expense
MarketingExpense
83000 USD
us-gaap Marketing Expense
MarketingExpense
63000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1241000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
704000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2121000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1762000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2652000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
921000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4754000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1838000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3858000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2703000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
5323000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
5082000 USD
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-134000 USD
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-95000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
-267000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
-1145000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
117000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
156000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
253000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3805000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2725000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5212000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
525000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1367000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
943000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2805000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2200000 USD
us-gaap Net Income Loss
NetIncomeLoss
3845000 USD
us-gaap Net Income Loss
NetIncomeLoss
3247000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
1009000 USD
ins Noncash Interest Income
NoncashInterestIncome
55000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8797691
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8924988
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8848351
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8924988
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8828773
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9019025
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8880831
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9020470
CY2021Q2 us-gaap Profit Loss
ProfitLoss
2805000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
2200000 USD
us-gaap Profit Loss
ProfitLoss
3845000 USD
us-gaap Profit Loss
ProfitLoss
3247000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2809000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2185000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3853000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3201000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
37289000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1047000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
38367000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
2200000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-15000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
40613000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44151000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2712000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
107000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1040000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
42647000 USD
CY2021Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5048000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
2805000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
198000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
40606000 USD
us-gaap Net Income Loss
NetIncomeLoss
3845000 USD
us-gaap Net Income Loss
NetIncomeLoss
3247000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1769000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
691000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
255000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
123000 USD
us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-267000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-176000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3778000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-623000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
114000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
153000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
37000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
9000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
552000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
467000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-854000 USD
ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
-282000 USD
ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
4112000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
33000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
85000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2605000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
705000 USD
ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
88000 USD
ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-14000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
405000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9714000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2612000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2767000 USD
ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
550000 USD
ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
1000000 USD
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
55000 USD
us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
400000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4507000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3767000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
107000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7759000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7652000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-46000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11746000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5901000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37956000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26415000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26210000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32316000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1754000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13355000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8053000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22267000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15946000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13355000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8053000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
22267000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15946000 USD
CY2018Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
250000 USD
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2020Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
750000 USD
CY2021Q2 ins Number Of Stockbased Compensation Plans In Effect
NumberOfStockbasedCompensationPlansInEffect
3 pure
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
198000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
255000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
123000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
74000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67500
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.35
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
893620 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
49000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
16.81
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
778920 USD
CY2021Q2 ins Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
3781000 USD
CY2020Q4 ins Operating Lease Rightofuse Asset And Lease Liability
OperatingLeaseRightofuseAssetAndLeaseLiability
2889000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038 pure
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
575000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
449000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
622000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1107000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1031000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
808000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
406000 USD
CY2021Q2 ins Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
73000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4047000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
290000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
291000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
575000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
449000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 USD

Files In Submission

Name View Source Status
0001437749-21-018617-index-headers.html Edgar Link pending
0001437749-21-018617-index.html Edgar Link pending
0001437749-21-018617.txt Edgar Link pending
0001437749-21-018617-xbrl.zip Edgar Link pending
ex_268544.htm Edgar Link pending
ex_268545.htm Edgar Link pending
ex_268546.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ins-20210630.xsd Edgar Link pending
ins-20210630_cal.xml Edgar Link unprocessable
ins-20210630_def.xml Edgar Link unprocessable
ins-20210630_lab.xml Edgar Link unprocessable
ins-20210630_pre.xml Edgar Link unprocessable
ins20210630_10q.htm Edgar Link pending
ins20210630_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending